LakeShore Biopharma CoLSBCF Days Inventory is 912.76 as of Mar. 2025, which is 83% above its 10-year median of 498.25. The stock has 5 warning signs investors should review. Among 640 Biotechnology companies, LakeShore Biopharma Co ranks worse than 86.72% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
LakeShore Biopharma Co's Inventory Turnover for the
six
months ended in Mar. 2025 was 0.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LakeShore Biopharma Co's Inventory-to-Revenue for the
six
months ended in Mar. 2025 was 0.89.
LakeShore Biopharma Co (OTCPK:LSBCF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
LakeShore Biopharma Co's Inventory Turnover for the
six
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LakeShore Biopharma Co's Inventory to Revenue for the
six
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
LakeShore Biopharma Co Days Inventory Related Terms
LakeShore Biopharma Co Days Inventory Historical Data
* Premium members only.
The historical data trend for LakeShore Biopharma Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSBCF vs ACUT, PPCB, ENSC: Days Inventory Comparison
For the Biotechnology subindustry, LakeShore Biopharma Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LakeShore Biopharma Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where LakeShore Biopharma Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LakeShore Biopharma Co (LSBCF) has a Days Inventory of 912.76 as of Mar. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LakeShore Biopharma Co and its competitors. This is 83% above median its historical median of 498.25. Over the past decade, LakeShore Biopharma Co's Days Inventory has ranged from 383.30 to 732.14. According to the industry distribution chart, LakeShore Biopharma Co ranks #555 out of 640 companies in the Biotechnology industry, placing it in the top 86.7%.
Is LakeShore Biopharma Co's Days Inventory too high?
LakeShore Biopharma Co's current Days Inventory of 912.76 is 83% above median its 10-year median of 498.25. Over the past 10 years, this metric has ranged from a low of 383.30 to a high of 732.14. The Biotechnology industry median Days Inventory is 184.15. LakeShore Biopharma Co's value of 912.76 is 395.7% above this industry median. Based on the distribution chart, LakeShore Biopharma Co ranks #555 out of 640 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does LakeShore Biopharma Co's Days Inventory compare to ACUT and PPCB?
According to the Biotechnology industry distribution chart, LakeShore Biopharma Co ranks #555 out of 640 companies for Days Inventory. This places LakeShore Biopharma Co in the lower half of its industry. The industry median Days Inventory is 184.15. LakeShore Biopharma Co's value of 912.76 is 395.7% above this benchmark. Historically, LakeShore Biopharma Co's own Days Inventory has ranged from 383.30 to 732.14 over the past decade. While the company's 10-year median is 498.25 vs. the industry median of 184.15, LakeShore Biopharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LakeShore Biopharma Co's current Days Inventory of 912.76 is 395.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LakeShore Biopharma Co and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LakeShore Biopharma Co's current Days Inventory is 912.76, which is 83% above median its own 10-year median of 498.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Days Inventory of 912.76. The current Days Inventory is 912.76, which is 83% above median its 10-year median of 498.25 and 395.7% above the Biotechnology industry median of 184.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Days Inventory is 912.76 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSBCF has been successfully added to your 